Akebia Therapeutics Stock Forecast, Price & News (NASDAQ:AKBA) Downgraded by BidaskClub to Strong Sell

Akebia Therapeutics Stock Forecast, Price & News stock has undergone multiple analysts rating changes in the recent past.  Akebia Therapeutics Stock Forecast, Price & News Downgraded by BidaskClub on 9/28/2020. In a note to investors, the firm issued a new rating of Strong Sell. The analysts previously had rating of Sell.

View More Akebia Therapeutics Stock Forecast, Price & News (NASDAQ:AKBA) Downgraded by BidaskClub to Strong Sell